Ring chromosomes are structural aberrations commonly associated with birth defects, mental disabilities and growth retardation 1, 2 . Rings form after fusion of the long and short arms of a chromosome, and are sometimes associated with large terminal deletions 2 .
Owing to the severity of these large aberrations that can affect multiple contiguous genes, no possible therapeutic strategies for ring chromosome disorders have been proposed. During cell division, ring chromosomes can exhibit unstable behaviour leading to continuous production of aneuploid progeny with low viability and high cellular death rate [3] [4] [5] [6] [7] [8] [9] . The overall consequences of this chromosomal instability have been largely unexplored in experimental model systems. Here we generated human induced pluripotent stem cells (iPSCs) [10] [11] [12] from patient fibroblasts containing ring chromosomes with large deletions and found that reprogrammed cells lost the abnormal chromosome and duplicated the wild-type homologue through the compensatory uniparental disomy (UPD) mechanism. The karyotypically normal iPSCs with isodisomy for the corrected chromosome outgrew co-existing aneuploid populations, enabling rapid and efficient isolation of patient-derived iPSCs devoid of the original chromosomal aberration. Our results suggest a fundamentally different function for cellular reprogramming as a means of 'chromosome therapy' 13 to reverse combined loss-of-function across many genes in cells with large-scale aberrations involving ring structures. In addition, our work provides an experimentally tractable human cellular system for studying mechanisms of chromosomal number control, which is of critical relevance to human development and disease.
We obtained fibroblasts from a Miller Dieker Syndrome (MDS) patient with ring chromosome 17, subsequently referred to as r (17) . MDS is caused by heterozygous deletions of human band 17p13. 3 (refs 14, 15) (Fig. 1a ). This deletion alone leads to craniofacial dysmorphology, defective neuronal migration, abnormal cortical layering and nearly absent cortical folding with devastating neurological consequences such as mental retardation and intractable epilepsy 14, 16 . However, in this case the 17p13.3 deletion was in a ring chromosome, and the patient had a typical MDS phenotype 14 . To separate the effects of r(17) from the 17p13.3 deletion, we obtained fibroblasts from two additional MDS patients with similar deletions but without r (17) (Fig. 1b) .
Two critical genes deleted in MDS are PAFAH1B1 (encoding LIS1) and YWHAE (encoding 14-3-3e) ( Fig. 1a) 15 . Consistent with this, MDS fibroblasts MDS1r (17) , MDS2 and MDS3 (Fig. 1c ) expressed reduced PAFAH1B1 and YWHAE messenger RNA compared to control fibroblasts ( Fig. 1d, e ). MDS1r (17) fibroblasts had a 46,XY,r(17) karyotype in 95% of the cells (Figs 1i and 2a and Extended Data Fig. 1) , with the remaining 5% exhibiting ring loss or secondary ring derivatives (Fig. 2b) .
To investigate the behaviour of ring chromosomes in actively proliferating cells, we generated iPSCs using non-integrating episomal vectors 17 . All MDS iPSCs were morphologically indistinguishable from wild type ( Fig. 1f ) and expressed stem cell markers ( Fig. 1g and Extended Data Fig. 2a-d ). We confirmed that MDS iPSCs were free of exogenous factor integration (Extended Data Fig. 3a , b) and were functionally pluripotent, producing cell types of the three germ layers (Extended Data Figs 4 and 5).
We then analysed six early-passage MDS1r(17) iPSC clones for the presence of the ring ( Fig. 1h ) and, unexpectedly, found that four out of six clones did not have any detectable ring chromosomes ( Fig. 1i ), but grew well and had proper morphology (Extended Data Fig. 6a ). In contrast, two other clones with detectable ring chromosomes ( Fig. 1i ) differentiated or stopped growing upon subsequent passaging (Extended Data Fig. 6b , c). Analysis of chromosome composition revealed that stable clones had 46 chromosomes and no ring in 85-100% of cells, in contrast to ,15% of cells in unstable clones ( Fig. 1i and Extended Data Fig. 6d, e ). These results suggested that r(17) was incompatible with reprogramming and/or stem cell maintenance using our methods.
Further cytogenetic analysis of the first two MDS1r(17) iPSC clones demonstrated a normal 46,XY karyotype without r(17) ( Fig. 2a-c ). In addition, the deletion, which was readily detectible by Giemsa (G)banding in MDS2 and MDS3 iPSCs, was not apparent in MDS1r(17) iPSCs ( Fig. 2a and Extended Data Fig. 1 ). These findings could be explained by either clonal expansion of rare cells with a normal karyotype from mosaic fibroblasts; or repair or replacement of the ring chromosome during or after reprogramming. We reasoned that presence of a small fraction of cells with the deleted r(17) in predominantly corrected iPSC clones would confirm their origin from an abnormal fibroblast. To test this, we analysed interphase nuclei by fluorescence in situ hybridization (FISH) using a red probe to detect the sub-telomeric band 17p13.3 together with a green probe to detect the long-arm band 17q21.32 ( Fig. 2d, e ). Consistent with karyotype data, $80% of cells in iPSC clones 1 and 2 demonstrated a normal signal pattern (2R2G) ( Fig. 2f ), suggesting that they have two intact copies of chromosome 17. However, 10-20% of interphase iPSCs had a 1R2G signal pattern, indicative of r(17) with p13.3 deletion ( Fig. 2f ). These results revealed persistent mosaicism in MDS1r(17) iPSCs, confirming their origin from ring-containing fibroblasts and supporting the hypothesis that repair or replacement of the ring chromosome occurred during reprogramming. Of note, despite several attempts (.120 cells analysed in multiple experiments), no evidence of r (17) was found in metaphase iPSCs, suggesting that in the pluripotent state such cells may be terminal and non-dividing. The expectation is that remaining interphase cells with r(17) would be gradually depleted. Cytogenetic and FISH results suggested that the MDS-associated deletion was rescued in MDS1r(17) iPSC clones 1 and 2. Consistent with that rescue, PAFAH1B1 genomic DNA levels were restored from 50% of wild type in the original fibroblasts ( Fig. 2g ) to wild-type levels in iPSCs ( Fig. 2h ). Conversely, in MDS2 and MDS3 cells without r(17), PAFAH1B1 genomic DNA levels were consistently reduced before and after reprogramming ( Fig. 2g , h). Similar results demonstrating rescue were obtained by western blot analysis for LIS1 and 14-3-3e proteins (Fig. 2i, j) . To investigate the status of the deleted locus before and after reprogramming in more detail, we performed single nucleotide polymorphism (SNP) microarrays. Analysis of total copy number for SNPs on chromosome 17 showed a clear decrease between positions 1 and 5,700,000 in MDS1r(17) fibroblasts, which was not observed in the corresponding iPSCs ( Fig. 3a, b ). In contrast, large terminal deletions were apparent in iPSCs derived from MDS2 and MDS3 fibroblasts ( Fig. 3c, d ). Of note, the extent of the deletion in MDS3 cells was exactly the same as in MDS1r (17) fibroblasts, making it an ideal control for the effect of the ring. Therefore, 17p13.3 deletion is recapitulated in iPSCs, and does not severely compromise pluripotent stem cell growth, viability or function. In contrast, r(17) appears to compromise in vitro stem cell maintenance and proliferation, and iPSCs that lost or repaired the ring chromosome showed preferential survival.
MDS
We proposed two possible mechanisms that could lead to loss of r (17) and rescue of the deleted locus. The first mechanism, called compensatory uniparental disomy (UPD), also referred to as monosomy correction, is known to occur during human development, and involves replacement of an abnormal chromosome with a copy of its normal homologue 18 . This is a two-step process that could proceed through loss of r(17) due to anaphase lag, followed by duplication of the wild type chromosome 17 by nondisjunction ( Fig. 3e ). The second mechanism could occur through a ring opening owing to a double-strand break 19 , followed by homology-based repair or somatic recombination 20, 21 with the wild-type homologue (Fig. 3e ). In both cases selection is likely to favour cells with 46 normal chromosomes. However, in the first scenario we would expect both chromosomes 17 in iPSCs to be isodisomic; that is, completely homozygous, whereas in the second scenario we would expect partial loss of heterozygosity (LOH) at the repaired locus with the rest of chromosome 17 being heterozygous (Fig. 3e ). To distinguish between these possibilities, we used data from SNP arrays to determine heterozygosity on chromosome 17 in fibroblasts and iPSCs. Consistent with compensatory UPD, the two homologues of chromosome 17 were entirely homozygous in both iPSC clones derived from MDS1r (17) cells, whereas the original fibroblasts as well as MDS2 and MDS3 iPSCs exhibited 27% heterozygosity (Fig. 3f ). This was a specific effect for the corrected chromosome 17 (Fig. 3g ).
Non-random gain of a third chromosome 17 occurs frequently in long-term culture of human pluripotent cells owing to a proliferative growth advantage [22] [23] [24] [25] . To test whether chromosomes not typically gained or implicated in advantageous stem cell growth can replace the corresponding ring chromosome in iPSCs, we reprogrammed fibroblasts from two additional cases involving ring chromosome 13, subsequently referred to as r (13), with large deletions (Fig. 4a , f) associated with multiple congenital anomalies. We confirmed the presence of r(13) in approximately 80-100% of the fibroblasts, with the remaining cells exhibiting Fib MDS1r (17) MDS1r (17) Fib MDS1r (17) MDS1r (17) 
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45 chromosomes minus r (13) or non-clonal aberrations involving the ring structure (Fig. 4b, d and Extended Data Fig. 7a, d) . Initial examination of iPSCs at passage six revealed 46,XY,r(13) karyotypes, although a fraction of cells had lost the ring chromosome ( Fig. 4c, e ). However, six out of nine clones that were examined after passage eight had a normal karyotype (Fig. 4a , c, e and Extended Data Fig. 7 ). In addition, GM00285 iPSC clone 4 transitioned from predominantly 46,XY,r(13) at passage six to 46,XY at passage twelve (Fig. 4c ). These results demonstrate dynamic mosaicism between clonally related cells, leading to preferential survival of karyotypically normal iPSCs in a matter of six passages, which did not occur in the fibroblasts (Fig. 4b, d ). In agreement, FISH studies revealed normal signal patterns in the corrected iPSC clones ( Fig. 4f-h ). Finally, SNP microarray analysis confirmed rescue of the deleted regions (Extended Data Fig. 8a-e ) and showed that corrected iPSCs are completely homozygous for chromosome 13 (Extended Data Fig. 8f, g) . The repaired iPSCs expressed stem cell markers (Extended Data Fig. 2e-j) , differentiated into three germ layers (Extended Data Fig. 9 ), and were free of exogenous factor integration (Extended Data Fig. 3c, d) . All of the established iPSC lines in this study were confirmed to be identical to their original fibroblasts by DNA fingerprinting (Extended Data Table 1 ). Finally, to further rule out the possibility that repaired iPSC clones originated from rare 46,XY fibroblasts, we measured the reprogramming rates for the lines used in this study. If there is a bias against reprogramming from cells with ring chromosomes, then we would expect reduced reprogramming efficiency from ring-containing fibroblast populations. However, we found no significant difference between wild-type and MDS cells, while reprogramming efficiency from r (13) fibroblasts was increased compared to wild type (Fig. 4i ). Therefore, r (17) or r(13) chromosomes do not interfere with episomal reprogramming. More likely, reprogramming increases cell divisions, increasing the probability that random nondisjunction compensates for the loss of the corresponding ring. Nondisjunction leading to chromosomal trisomy is the most commonly reported karyotypic change in cultured human ES cells and iPSCs 23 , because mitotic checkpoints that ensure proper alignment and disentanglement of sister chromatids before separation are less efficient than in differentiated cells 23, [26] [27] [28] . In this case, isodisomic cells have a growth advantage over cells with ring chromosomes including large deletions; however, they are not exactly the same as wild type. UPD could lead to undesirable clinical consequences through homozygosity for a recessive mutation or disruption of imprinting 18 . Thus, expression of imprinted genes and presence of recessive mutations would have to be carefully monitored and/or corrected for any therapeutic applications.
Compensatory UPD and dynamic mosaicism occur in actively proliferating cells in vivo, including cases involving ring chromosome 21, in which patients' lymphocytes transitioned from predominantly 46,XX,r(21) to 46,XX (with UPD21) several years later 29, 30 . These observations further suggest that taking advantage of this intrinsic property of iPSCs may be a feasible approach to correct combined loss-of-function and structural aberrations associated with additional ring chromosomes. Given that repair of large deletions involving multiple genes is not possible with current genome editing techniques, our results may have broad implications for regenerative medicine and advance the newly emerging concept of chromosome therapy 13 . More broadly, our findings underscore the importance of studying chromosome repair in stem cells and establish a novel platform for investigating the mechanisms that regulate chromosome number during early human development.
METHODS SUMMARY
The following primary human cells were used in this study: MDS1r(17) (GM06047), MDS2 (GM06097), MDS3 (GM09208), GM00285 and GM05563 (Coriell Institute for Medical Research); BJ and Detroit 551 (ATCC); HDF-1323 from a 48-year-old caucasian female (Cell Applications; 106-05a); HDF-WTc from a 30-year-old Japanese male, whose skin samples were collected at Gladstone. Human iPSCs were generated with the episomal Y4 plasmid mixture as described 17 with some modifications (available in the online Methods). Established hiPSC lines were cultured in mTeSR1 medium (Stem Cell Technologies) on dishes coated with Matrigel (BD) or Synthemax (Corning). Chromosomal analyses were performed on 20 G-banded metaphase cells from each sample and FISH analyses were performed on two hundred interphase nuclei from each sample at Cell Line Genetics or the 
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University of California San Francisco cytogenetics laboratory. SNP genotyping to determine CNV presence and UPD status was performed using the Affymetrix Axiom EUR array platform by the Genomics Core Facility (GCF) at the University of California San Francisco for MDS samples and using the Agilent SurePrint G3 Human CGH 1 SNP 4 3 180K array platform by Cell Line Genetics for r(13) samples.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Cell culture. Human iPSCs were generated from human dermal fibroblasts (HDFs) within six passages after receipt. The study involved use of existing specimens that are publicly available and provided without any identifiers linked to the subjects. All procedures were approved by the UCSF Committee on Human Research and the Germ and Embryonic Stem Cell Research Committee. Human fibroblasts and SNL feeder cells (Health Protection Agency Culture Collection) were cultured in DMEM containing 10% FBS, 1% GlutaMAX, 0.1 mM MEM non-essential amino acids (Invitrogen), 1 mM sodium pyruvate, and penicillin-streptomycin (all from Invitrogen). For passaging, fibroblasts were washed once with Dulbecco's PBS (DPBS; calcium and magnesium free) and incubated with TrypLE Express (Invitrogen) at 37 uC. When cells were dissociated, the TrypLE Express was removed, and the cells were washed with culture medium described above. The cells were collected into a 15-ml conical tube and spun down. The contents were transferred to a new dish. The split ratio was routinely 1:3 to 1:20. Established human iPSC lines were cultured in mTeSR1 medium (Stem Cell Technologies) on dishes coated with Matrigel (BD) or Synthemax (Corning). For passaging, human iPSCs were washed once with DPBS and incubated with Accutase (Millipore) at 37 uC. When colonies at the edge of the dish started dissociating from the bottom, Accutase was removed, and mTeSR1 medium was added. Cells were scraped and replated into new dishes in mTeSR1 with 10 mM ROCK inhibitor (Y-27632: Millipore). The split ratio was routinely 1:3 to 1:20. The next day, the medium was replaced with mTeSR1 without ROCK inhibitor. Generation of human iPSCs with episomal vectors. Human iPSCs were generated with episomal plasmids as described 17 with some modifications. Three micrograms of expression plasmid mixtures (epiY4) were electroporated into 3 3 10 5 fibroblasts with a Neon Electroporation Device (Invitrogen) with a 100-ml kit, according to the manufacturer's instructions. Conditions for electroporations were 1,650 V, 10 ms, and three pulses. Cells were detached within 1 week after electroporation and seeded at 1-33 10 5 cells per 10-cm dish onto irradiated or mitomycin-C treated SNL feeder cells. The culture medium was replaced the next day with primate ESC medium (Reprocell) containing basic fibroblast growth factor (FGF). Colonies were counted 25 days after electroporation, and those colonies similar to human ESCs were selected for further cultivation and evaluation. For calculating reprogramming efficiency, 1 3 10 4 electroporated cells were seeded per well of 6-well plate, and the number of TRA-1-60 positive colonies were counted on day 25. The generation and characterization of WT iPSC clones from BJ and HDF-1323 was previously described 31 . These lines were free of episomal integration, maintained pluripotency, self-renewal and normal karyotype 31 . In vitro differentiation. For embryoid-body formation from human iPSCs, the cells were collected by treating with Accutase. The clumps of the cells were transferred to ultra-low-attachment dishes (Corning) in DMEM/F12 containing 20% knockout serum replacement (KSR, Invitrogen), 2 mM L-glutamine, 100 mM nonessential amino acids, 100 mM 2-mercaptoethanol (Invitrogen), and penicillinstreptomycin. The medium was changed every other day. After 8 days as a floating culture, embryoid bodies were transferred to gelatin-coated plate and cultured in the same medium for another 8 days. Teratoma formation. Human iPSCs cells were dissociated by Accutase treatment. Cell pellets were resuspended in mTeSR1 complete medium with 10 mM Rock inhibitor, Y-27632. One confluent well of cells from a 6-well plate was used for each injection into the testis of 8-10-week-old CB17 SCID male mice (Charles River). Tumour samples were collected 6.5-11 weeks after injection, fixed with PBS containing 4% paraformaldehyde, and processed for paraffin-embedded sections by the Gladstone Histology and Microscopy Core. All mouse studies were approved by the UCSF Institutional Animal Care and Use and Committee. Immunocytochemistry. For counting the TRA-1-60-positive colonies in hiPSC generation experiments, cells were fixed with PBS containing 4% paraformaldehyde for 10 min at room temperature (22-25 uC) and reacted with ImmunoPure Peroxidase Suppressor (Thermo Scientific). The cells were washed with PBS and treated with 1% BSA for blocking. Primary antibodies used were biotin-conjugated anti-TRA-1-60 antibody (1 mg ml 21 , eBiosciences). Immunostaining was performed using HRP-conjugated streptavidin (1 mg ml 21 , Thermo Scientific) and ImmunoHisto Peroxidase Detection Kit (Thermo Scientific), according to the manufacturer's instructions. For immunocytochemistry of pluripotency and differentiation markers, cells were fixed with PBS containing 4% paraformaldehyde for 10 min at room temperature, permeabilized with PBS containing 0.1% Triton X-100 for 10 min at room temperature and then washed with PBS and treated with 1% BSA for blocking. The following primary antibodies were used: SSEA3 (0.5 mg ml 21 , eBiosciences), SSEA4 (0.5 mg ml 21 , eBiosciences), TRA-1-60 (0.5 mg ml 21 , eBiosciences), TRA-1-81 (0.5 mg ml 21 , eBiosciences; 1:250, MAB4381, Millipore), NANOG (2 mg ml 21 , AF1997, R&D Systems; 1:250, Ab21624, Abcam), SOX2 (1:500, Ab59776, Abcam), OCT3/4 (1:250, sc-5279, Santa Cruz), OCT4 (1:250, 09-0023, Stemgent), KLF4 (1:100, Ab75486, Abcam), bIII-tubulin, aka TUJ1 (1:100, MAB1637, Millipore; 1:1,000, MMS-435P, Covance), a-smooth muscle actin, also known as SMA (prediluted, N1584, DAKO; 1:200, A2547, Sigma), a-fetoprotein aka AFP (2 mg ml 21 , MAB1368, R&D Systems; 1:200, A8452, Sigma), and MAP2 (1:200, MAB3418, Millipore). Secondary antibodies used were Alexafluor488 or 555-conjugated goat anti-mouse IgG (1:200, Invitrogen), Alexa488 or 555-conjugated goat anti-rabbit IgG (1:200, Invitrogen), and Alexa488 or 555-conjugated donkey anti-goat IgG (1:200, Invitrogen) . Nuclei were stained with DAPI contained in the Vectashield set (Vector Laboratories) or DAPI in ProLong gold antifade reagent (Invitrogen). Western blot analysis. Cells were lysed with RIPA buffer (150 mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) supplemented with protease and phosphotase inhibitor cocktails (Roche). Protein concentration was determined with BCA assay (Biorad) according to the manufacturer's instructions, and samples were then diluted to the same concentration with lysis buffer. Prior to loading, samples were denatured with Laemmli 63 buffer and boiled for 5 min. Equal amounts of total protein (typical range 15-30 mg) were loaded onto 4-20% TGX gradient gels (Biorad) and separated by SDS-PAGE. Proteins were transferred onto nitrocellulose membranes (Biorad), blocked for 1 h using TBS-T (Tris-buffered saline mixed with Tween 20) containing 5% non-fat dry milk, incubated with primary antibodies in blocking buffer overnight at 4 uC, rinsed with TBS-T, and incubated with secondary antibodies in blocking buffer for 1 h at room temperature. The following primary antibodies were used: SOX2 (1:1,000, Ab59776, Abcam), OCT3/4 (1:250, sc-5279, Santa Cruz), NANOG (1:250, Ab21624, Abcam), ACTIN (1:10,000, A2228, Sigma), LIS1 (1:1,000, kind gift of S. Hirotsune), 14-3-3e (1:250, sc-1020, Santa Cruz), GAPDH (1:5,000, ACR001P, Acris), a-TUBULIN (1:2,000, T6074, Sigma). HRP-conjugated secondary antibodies (Jackson Immunoresearch Laboratories) were used at 1:10,000. Development was done with ECL detection kits (Pierce) according to manufacturer's instructions. Quantitative PCR. Genomic DNA was isolated with QIAmp DNA micro kit (Qiagen). To isolate RNA, cells were lysed with TRIzol reagent. Following chloroform extraction, aqueous phase containing RNA was mixed with 70% ethanol, transferred onto a mini spin column, isolated with RNeasy mini kit (Qiagen), and digested with DNase I (Qiagen). The quality and concentration of DNA and RNA were assessed using a Nanodrop 1000 spectrophotometer (Thermo Scientific). cDNA was prepared using the iScript cDNA synthesis kit (Biorad). qPCR was carried out using the SsoFast EvaGreen Supermix (Biorad) with a Vii7 instrument (Applied Biosystems). To check exogenous reprogramming factor integration, we performed qPCR on genomic DNA isolated from iPSCs, using published primers 17 . To measure endogenous genomic DNA levels by qPCR, the following primers sets were used: PAFAH1B1 (set 1, forward 59-ACCCTTCAGGGCTTTCATTT-39, reverse 59-CCATTGGGCATAGGTCTCAT-39; set 4, forward 59-TTCTCGCCTG AACCATCTTT-39, reverse 59-GTGCTGCCTGTAGTGTGGAA-39) normalized to ACTA1 (forward 59-CAGAGAGGATGGGCACTAGC-39, reverse 59-CGAGA CCCCACTGAGAAGTC-39) and B2M (forward 59-TGCTGTCTCCATGTTTGA TGTATCT-39, reverse 59-TCTCTGCTCCCCACCTCTAAGT-39). For qPCR from cDNA, the following primers were used: PAFAH1B1 (forward 59-TGGGTACGT GGAGTTCTGTT, reverse 59-TGTGGAAATCCAAGGAGGTA-39), YWHAE (forward 59-ATGGATGTGGAGCTGACAGT-39, reverse 59-CCAGTGTTAGC TGCTGGAAT-39) normalized to TBP (forward 59-TATAATCCCAAGCGGTTT GC-39, reverse 59-GCTGGAAAACCCAACTTCTG-39). We calculated amplification efficiency (E) for all the primers above, and ensured that percentage efficiency was close to 100% (65%) in order to detect twofold differences. Relative ratios were determined using Pfaffl method 32 , taking into account primer efficiency. SNP genotyping and CNV calling. SNP genotyping to determine CNV presence and UPD status for MDS samples was performed using the Affymetrix Axiom EUR array platform by the Genomics Core Facility (GCF) at UCSF, using standard protocols. The Axiom EUR array assays approximately 675,000 SNPs across the genome, and is optimized for genome-wide, gene-based and candidate-SNP coverage 33 . SNP genotype calls were generated using the 'apt-probeset-genotype' function in Affymetrix Power Tools. Heterozygosity was determined in R 34 by counting the number of individuals with homozygous genotypes and the ones with heterozygous genotypes. This has been done on chromosome 17, the chromosome of interest, and chromosome 16, the control chromosome.
For CNV estimation and visualization, we used a similar procedure to previous successful methods, as available CNV calling tools such as PennCNV, QuantiSNP and Birdsuite are not able to handle Axiom data. First, quantile normalization transforms the quantiles for each array to have the same distribution 35 . This was performed using the apt-probeset-genotype function in Affymetrix Power Tools on a complete plate of arrays (n 5 95). Second, to estimate integer copy number, we use the copy number polymorphism evaluation routine (COPPER), previously developed to call CNVs from SNP array data 36 . In brief, COPPER uses genotype calls to set the median for 0, 1 and 2 copies of each allele and transform the intensity axes appropriately to derive scaled intensity estimates. This procedure was implemented RESEARCH LETTER in R. After quantile normalization and COPPER, we sum up the intensities on each axis, which represents a total copy-number estimate at each locus for each individual.
After the first iteration of this procedure, genome-wide variability in each individual's copy number graph is manually assessed and individuals with excess variability are excluded. Typical individuals have variance of approximately 1, so individuals with variance across entire chromosomes ?1 are excluded, leaving 87 samples in this case for the second run of quantile normalization and COPPER to perform CNV calling. To take into account the non-independence of consecutive SNPs, we utilize a 5-SNP median, as the copy number of a locus is estimated more accurately by including information from SNP probes on each side. We then apply a hidden Markov model to make the CNV calls, similar to QuantiSNP 37 , implemented in Python.
SNP genotyping to determine CNV presence and UPD status for r(13) samples was performed using the Agilent SurePrint G3 Human CGH 1 SNP 4 3 180K array platform by Cell Line Genetics, using standard protocols. Labelling reactions were prepared using the Agilent Enzymatic Labelling Protocol for aCGH (version 7.1) with 1 mg total DNA input. The protocol consists of two parts: labelling of the DNA and hybridization. First, 1 mg of DNA is fragmented with restriction enzymes and the test DNA labelled with the cyanine-5-labelled analogue of deoxyuridine triphosphate (5-dUTP) and reference DNA with cyanine 3-dUTP by ExoKlenow fragment. Labelled DNA is then purified using Millipore Amicon Ultracel-30 filters and the labelling efficiency determined by the NanoDrop spectrophotometer. Next, the labelled DNA is prepared for hybridization with human Cot1 DNA and placed on the Sureprint G3 human CGH 1 SNP 4 3 180k microarray and hybridized at 65 uC for approximately 24 h. Finally, the arrays are washed and scanned at 3 mM resolution on an Agilent G2565CA High Resolution Scanner. Data were processed through Agilent's Feature Extraction software version 11.0.1.1 using the protocol CGH_1100_Jul11 and the 029830_D_F_20100916 grid file. Analyses of CNV estimation and visualization were performed using Agilent genomic Workbench 7.0 software. Karyotype and FISH analysis. Non-banded chromosome number and ring status analyses were performed as described previously 38 . DNA was stained with DAPI in ProLong gold antifade reagent (Invitrogen) and mitotic chromosomes were visualized using a 3100 objective on a Leica TCS SP5 confocal microscope. Additional chromosomal analyses were performed on twenty G-banded metaphase cells from each sample at Cell Line Genetics or the UCSF cytogenetics laboratory. FISH analyses were performed on two hundred interphase nuclei from each sample at Cell Line Genetics as described previously 38 . A green probe to detect the pericentromeric long-arm band 13q12.12 together with a red probe to detect the subtelomeric band 13q34 were used for chromosome 13. A green probe to detect the subtelomeric long-arm band 17q21.32 together with a red probe to detect the subtelomeric shortarm band 17p13.3 were used for chromosome 17. DNA fingerprinting. The short tandem repeat (STR) profile assays were performed at Cell Line Genetics. They used the Powerplex 16 (Promega) kit and followed the manufacturer's recommendation to obtain the results. These samples were run in duplicate and blinded to the interpreter. All the established iPSC lines in this study were confirmed to be identical with their original fibroblasts by DNA fingerprinting ( Supplementary Table 1 ).
